Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.995    -0.215 (-9.73%)
Bid:
1.905
Ask:
2.19
Spread: 0.285 (14.961%)
Market Cap: £40.02m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Form 8.5 (EPT/RI) - Quintain Estates & Dev Plc

28 Aug 2015 11:11

RNS Number : 4511X
JPMorgan Securities Plc
28 August 2015
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Quintain Estates and Development Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Quintain Estates and Development Plc

(d) Date dealing undertaken:

27 August 2015

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(GBP)

Lowest price per unit paid/received

(GBP)

Ordinary Shares

Purchases

 

Sales

1,285,551

 

39,655

1.2988

 

1.3000

1.2938

 

1.2925

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBP)

 

Ordinary Shares

Equity Swap

Long

 

 

Short

38,000

120

 

10,517

1.2955

1.2962

 

1.2938

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (GBP)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit (GBP)

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(GBP)

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

(GBP)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

Date of disclosure:

28 August 2015

Contact name:

Jasper Niesing

Telephone number:

020 7742 4613

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERPKFDKKBKDCFB
Date   Source Headline
25th May 20117:00 amRNSFinal Results
13th May 20114:46 pmRNSDirector/PDMR Shareholding
13th May 201111:00 amRNSRe planning Consent at Wembley
3rd May 20112:32 pmRNSBlocklisting Interim Review
3rd May 20111:54 pmRNSTotal Voting Rights
13th Apr 20114:03 pmRNSDirector/PDMR Shareholding
12th Apr 201110:27 amRNSNotice of Results
25th Mar 20117:00 amRNSDirectorate Change
15th Mar 201112:04 pmRNSDirector/PDMR Shareholding
24th Feb 20117:00 amRNSInvestment in Albemarle Retail Properties LLP
16th Feb 201110:19 amRNSDirector/PDMR Shareholding
9th Feb 20117:00 amRNSInterim Management Statement
31st Jan 20118:51 amRNSDirector/PDMR Shareholding
28th Jan 20112:21 pmRNSNotice of IMS
18th Jan 20115:15 pmRNSDirector/PDMR Shareholding
31st Dec 201012:09 pmRNSTotal Voting Rights
22nd Dec 201011:47 amRNSHolding(s) in Company
16th Dec 20103:41 pmRNSDirector/PDMR Shareholding
26th Nov 201011:51 amRNSDirector/PDMR Shareholding
26th Nov 20107:00 amRNSHalf Yearly Report
24th Nov 20107:00 amRNSQuintain and Living PlanIT Announce Landmark Deal
16th Nov 20103:23 pmRNSDirector/PDMR Shareholding
21st Oct 20101:30 pmRNSNotice of Results
21st Oct 20101:30 pmRNSNotice of Results
15th Oct 20101:40 pmRNSDirector/PDMR Shareholding
4th Oct 20109:30 amRNSHolding(s) in Company
30th Sep 20107:00 amRNSPre Close Statement
20th Sep 20107:00 amRNSDirectorate Change
14th Sep 201010:36 amRNSDirector/PDMR Shareholding
13th Sep 20107:00 amRNSDirector/PDMR Shareholding
7th Sep 20101:48 pmRNSResult of AGM
7th Sep 20109:31 amRNSDirectorate Change
26th Aug 20104:01 pmRNSHolding(s) in Company
20th Aug 201012:27 pmRNSAnnual Information Update
13th Aug 20103:51 pmRNSDirector/PDMR Shareholding
10th Aug 20107:00 amRNSFirst Quarter Interim Management Statement
9th Aug 20107:00 amRNSDisposal
2nd Aug 20102:00 pmRNSNotice of AGM
29th Jul 20107:00 amRNSTotal Voting Rights
19th Jul 20103:21 pmRNSAnnual Report and Accounts
15th Jul 20107:00 amRNSDirector/PDMR Shareholding
25th Jun 201012:08 pmRNSTotal Voting Rights
15th Jun 201011:02 amRNSDirector/PDMR Shareholding
10th Jun 201012:31 pmRNSDirector/PDMR Shareholding
9th Jun 201012:18 pmRNSDirector/PDMR Shareholding
9th Jun 20109:44 amRNSDirector/PDMR Shareholding
3rd Jun 201012:10 pmRNSDirector/PDMR Shareholding
3rd Jun 20107:00 amRNSFinal Results
24th May 20107:00 amRNSCineworld to partner Quintain at Wembley
14th May 20104:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.